Kentaro Nagaoka Selected Research

PF-670462

12/2019

Effects of a selective casein kinase 1δ and ε inhibitor on FcεRI expression and IgE-mediated immediate-type cutaneous reactions in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Nagaoka Research Topics

Disease

6	Infections 12/2021 - 06/2013
6	Pneumonia (Pneumonitis) 01/2020 - 08/2013
4	Neoplasms (Cancer) 01/2021 - 01/2013
3	COVID-19 09/2022 - 12/2021
3	Inflammation (Inflammations) 01/2022 - 12/2011
3	Flushing 01/2021 - 08/2003
2	Periodontitis 01/2020 - 04/2013
2	Body Weight (Weight, Body) 01/2018 - 12/2016
2	Abscess 11/2013 - 06/2013
2	Ventilator-Associated Pneumonia 09/2013 - 08/2013
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Severe Acute Respiratory Syndrome 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Erythema 12/2019
1	Obesity 04/2019
1	Hypercholesterolemia 04/2019
1	Fever (Fevers) 02/2019
1	Disease Progression 02/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Liver Abscess 03/2017
1	Blood-Borne Infections 03/2017
1	Empyema 02/2017
1	Lung Abscess 02/2017
1	Lung Diseases (Lung Disease) 02/2017
1	Wounds and Injuries (Trauma) 12/2016
1	Bacteremia 01/2016
1	Hyperthyroidism 01/2015
1	Mastitis 12/2014
1	Leukopenia 06/2014
1	Pneumococcal Infections 02/2014
1	Pneumococcal Pneumonia 02/2014
1	Intellectual Disability (Idiocy) 11/2013
1	Fragile X Syndrome (Martin Bell Syndrome) 11/2013
1	Autistic Disorder (Autism) 11/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
4	Progesterone FDA LinkGeneric 01/2021 - 12/2007
3	VaccinesIBA 09/2022 - 12/2021
3	Azithromycin (Zithromax)FDA LinkGeneric 02/2019 - 08/2013
2	Hormones (Hormone)IBA 01/2021 - 12/2016
2	SteroidsIBA 01/2021 - 02/2019
2	MacrolidesIBA 02/2019 - 01/2019
2	Vancomycin FDA LinkGeneric 01/2019 - 02/2017
2	Daptomycin FDA Link 01/2019 - 06/2013
2	CorticosteroneIBA 01/2018 - 12/2007
2	Messenger RNA (mRNA)IBA 12/2014 - 08/2003
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2008 - 12/2007
2	ProlactinIBA 04/2008 - 12/2007
1	Biological ProductsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Hemolysin Proteins (Hemolysins)IBA 01/2020
1	Leukocidins (Leukocidin)IBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2020
1	Keratin-7 (Cytokeratin 7)IBA 01/2020
1	Keratin-20 (Cytokeratin 20)IBA 01/2020
1	A-factor (Streptomyces)IBA 12/2019
1	PF-670462IBA 12/2019
1	Immunoglobulin E (IgE)IBA 12/2019
1	Fluvastatin FDA Link 04/2019
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 04/2019
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 04/2019
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 02/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019
1	FluoroquinolonesIBA 02/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	CholesterolIBA 09/2017
1	DS-8587IBA 03/2017
1	Levofloxacin (Levaquin)FDA Link 03/2017
1	Bacterial DNAIBA 02/2017
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 02/2017
1	AgarIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	3-Hydroxysteroid Dehydrogenases (3 beta Hydroxysteroid Dehydrogenase)IBA 12/2016
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 12/2016
1	Hydroxysteroid DehydrogenasesIBA 12/2016
1	Caspase 3 (Caspase-3)IBA 12/2016
1	LyasesIBA 12/2016
1	SaccharinIBA 12/2016
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 12/2016
1	steroidogenic acute regulatory proteinIBA 12/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	QuinolonesIBA 06/2014
1	Serum AlbuminIBA 06/2014
1	platelet activating factor receptorIBA 02/2014
1	Anti-Infective Agents (Microbicides)IBA 11/2013
1	Fragile X Mental Retardation ProteinIBA 11/2013
1	biapenem (L 627)IBA 09/2013
1	ME1071IBA 09/2013
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 06/2013

Therapy/Procedure

2	Oral Hygiene (Dental Hygiene) 01/2020 - 02/2014
2	Therapeutics 02/2019 - 01/2016
1	Aftercare (After-Treatment) 02/2019